Gene: TRPV4
Official Full Name: transient receptor potential cation channel subfamily V member 4provided by HGNC
Gene Summary: This gene encodes a member of the OSM9-like transient receptor potential channel (OTRPC) subfamily in the transient receptor potential (TRP) superfamily of ion channels. The encoded protein is a Ca2+-permeable, nonselective cation channel that is thought to be involved in the regulation of systemic osmotic pressure. Mutations in this gene are the cause of spondylometaphyseal and metatropic dysplasia and hereditary motor and sensory neuropathy type IIC. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09552 | TRPV4 Knockout cell line (HEK293) | Human | TRPV4 | 1:3~1:6 | Negative | Online Inquiry |
TRPV4 Gene Knockout Cell Lines are advanced cellular models specifically engineered to study the role of the TRPV4 ion channel in various physiological and pathological contexts. Utilizing CRISPR-Cas9 technology, these cell lines exhibit a complete loss of TRPV4 expression, allowing researchers to investigate the channel's involvement in crucial processes such as mechanotransduction, osmoregulation, and thermosensation. The mechanism by which TRPV4 operates is centered on its ability to act as a calcium-permeable channel that responds to mechanical stimuli and changes in osmolarity, making it integral to the physiological response in multiple cell types, including sensory neurons, epithelial cells, and chondrocytes.
The scientific importance of TRPV4 Gene Knockout Cell Lines extends into diverse research areas, including pain modulation, inflammation, and bone density regulation. These models are invaluable in elucidating the signaling pathways activated by TRPV4, which have implications in conditions such as osteoarthritis and neuropathic pain, thereby fostering the development of novel therapeutic strategies.
Compared to traditional models, such as wild-type cell lines or pharmacological inhibition approaches, the TRPV4 knockout cell lines offer a more precise mechanism to study the loss of TRPV4 function without off-target effects or compensatory mechanisms that might skew results. They allow for clearer interpretations in experimental designs aimed at accentuating TRPV4's role, making them a unique asset in both basic and translational research.
For researchers and clinicians focused on understanding the nuances of ion channel behavior and its implications in health, these knockout cell lines provide a powerful platform for innovative studies. They enable the development of targeted treatments, thereby accelerating the pace of discovery in the field of cellular biology.
Capitalizing on years of expertise in genetic engineering and cell line development, our company delivers high-quality biological products like TRPV4 Gene Knockout Cell Lines that empower scientists to unlock new insights and drive forward the boundaries of biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.